Skip to main content
OpenTrials
Completed

NCT Number: NCT02464462

The Role of Vitamin D3 and Calcium Supplementation in Attenuating T2DM Severity

The purpose of this study is to investigate the effect of vitamin D3 and calcium supplementation in attenuating type 2 diabetes mellitus outcomes in ethnic diverse, diabetic patiens.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Subjects of this study received a total of 1800 IU vitamin D3 and 720 mg of calcium per day for 3 years. The study was conducted in Toronto, Ontario, Canada.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Type 2 diabetes mellitus
  • Non-white, post menopausal female
  • Have access to Community Health Center

Exclusion criteria

  • neurodegenerative disease
  • kideny disease
  • gluten allergy

Treatment and study plan

Vitamin D3 and Calcium

Dietary Supplement

1800 IU vitamin D3 plus 720 mg Calcium

Placebo

Other

Rice powder pills

Primary outcomes

  1. Serum calcidiol

    Time frame: 3 years

Secondary outcomes

  1. Fasting insulin

    Time frame: 3 years

  2. Parathyroid Hormone

    Time frame: 3 years

  3. Fasting blood glucose

    Time frame: 3 years

  4. Glycated Hemoglobin

    Time frame: 3 years

Sponsors and collaborators

Lead sponsor

York University

Other

Collaborators

  • Women's Health in Women's Hands Community Health Center

Registry information

Official study title

The Role of Vitamin D and Calcium Supplementation in the Pathogenesis of Type 2 Diabetes Mellitus

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Jun 8, 2015
Registry last updated
Jun 8, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.